OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SOHO State of the Art Updates and Next Questions: Targeted therapies and emerging novel treatment approaches for Waldenström Macroglobulinemia
David Sermer, Shayna Sarosiek, Andrew R. Branagan, et al.
Clinical Lymphoma Myeloma & Leukemia (2022) Vol. 22, Iss. 8, pp. 547-556
Open Access | Times Cited: 7
David Sermer, Shayna Sarosiek, Andrew R. Branagan, et al.
Clinical Lymphoma Myeloma & Leukemia (2022) Vol. 22, Iss. 8, pp. 547-556
Open Access | Times Cited: 7
Showing 7 citing articles:
Report of Consensus Panel 6 from the 11 th International Workshop on Waldenström's Macroglobulinemia on Management of Waldenström's Macroglobulinemia Related Amyloidosis
Giampaolo Merlini, Shayna Sarosiek, Giulia Benevolo, et al.
Seminars in Hematology (2023) Vol. 60, Iss. 2, pp. 113-117
Open Access | Times Cited: 7
Giampaolo Merlini, Shayna Sarosiek, Giulia Benevolo, et al.
Seminars in Hematology (2023) Vol. 60, Iss. 2, pp. 113-117
Open Access | Times Cited: 7
Broadening the horizon: potential applications of CAR-T cells beyond current indications
Hendrik Karsten, Ludwig Matrisch, Sophia Cichutek, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Hendrik Karsten, Ludwig Matrisch, Sophia Cichutek, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Anti-myelin-associated-glycoprotein neuropathy successfully treated with tirabrutinib
Hajime Yasuda, Yuji Tomizawa, Sakiko Harada, et al.
Heliyon (2022) Vol. 8, Iss. 10, pp. e10928-e10928
Open Access | Times Cited: 10
Hajime Yasuda, Yuji Tomizawa, Sakiko Harada, et al.
Heliyon (2022) Vol. 8, Iss. 10, pp. e10928-e10928
Open Access | Times Cited: 10
Evaluating orelabrutinib as a novel treatment option for relapsed/refractory chronic lymphocytic leukemia in China
Danling Gu, Jianyong Li, Yi Miao
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 18, pp. 1979-1986
Closed Access | Times Cited: 10
Danling Gu, Jianyong Li, Yi Miao
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 18, pp. 1979-1986
Closed Access | Times Cited: 10
Transcriptomic and proteomic differences in BTK-WT and BTK-mutated CLL and their changes during therapy with pirtobrutinib
Burcu Aslan, Ganiraju C. Manyam, LaKesla R. Iles, et al.
Blood Advances (2024) Vol. 8, Iss. 17, pp. 4487-4501
Open Access | Times Cited: 1
Burcu Aslan, Ganiraju C. Manyam, LaKesla R. Iles, et al.
Blood Advances (2024) Vol. 8, Iss. 17, pp. 4487-4501
Open Access | Times Cited: 1
A Canadian Perspective on the Treatment of Waldenström Macroglobulinemia
Rayan Kaedbey, Nicholas Forward, Laurie H. Sehn, et al.
Current Oncology (2022) Vol. 29, Iss. 10, pp. 7122-7139
Open Access | Times Cited: 2
Rayan Kaedbey, Nicholas Forward, Laurie H. Sehn, et al.
Current Oncology (2022) Vol. 29, Iss. 10, pp. 7122-7139
Open Access | Times Cited: 2
Sequence-Based Mechanistic Resolution of Amino Acid Replacement and Impact on the Activities of Peptide-Based Derivatives Targeting CXCR4 for the Treatment of Waldenström’s Macroglobulinemia
Ghazi Elamin, Opeyemi Soremekun, Shaban R. M. Sayed, et al.
Journal of Computational Biophysics and Chemistry (2023) Vol. 23, Iss. 02, pp. 207-221
Closed Access
Ghazi Elamin, Opeyemi Soremekun, Shaban R. M. Sayed, et al.
Journal of Computational Biophysics and Chemistry (2023) Vol. 23, Iss. 02, pp. 207-221
Closed Access
